Demant A/S (CPH:DEMANT)
233.20
-2.00 (-0.85%)
Oct 24, 2025, 4:00 PM CET
Demant Market Cap
Demant has a market cap or net worth of 50.1 billion as of October 24, 2025. Its market cap has decreased by -12.16% in one year.
Market Cap
50.10B
Enterprise Value
65.22B
Revenue
22.59B
Ranking
n/a
PE Ratio
18.81
Stock Price
233.20
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 50.10B, an increase of 2,264.43%. That is a compound annual growth rate of 11.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 50.10B | -12.89% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | 57.66B | 12.05% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.58T |
| Coloplast | 134.11B |
| Genmab | 118.06B |
| ALK-Abelló | 47.02B |
| H. Lundbeck | 43.39B |
| Zealand Pharma | 33.31B |
| Ambu A/S | 28.18B |
| Bavarian Nordic | 18.94B |